PI
RCUS icon

PEAK6 Investments’s Arcus Biosciences RCUS Stock Holding History

PEAK6 Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$229K Buy
+15,000
New +$237K ﹤0.01% 2716

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PEAK6 Investments's RCUS Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Arcus Biosciences (RCUS) in Q3 2024: 15,000 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #2716 among its holdings.

187 funds tracked by Wall St. Rank hold RCUS as of Q3 2024.

  • PEAK6 Investments held 15,000 shares of Arcus Biosciences worth $229K as of Q3 2024.
  • Arcus Biosciences was a new PEAK6 Investments position in Q3 2024.
  • Arcus Biosciences made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2716 holding.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.